BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8275034)

  • 1. The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation.
    Smyth LA; Witt CS; Christiansen FT; Herrmann RP; Hollingsworth PN; Townend DC; Edward E; Dawkins RL
    Bone Marrow Transplant; 1993 Oct; 12(4):351-5. PubMed ID: 8275034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex influences the development of acute graft-versus-host disease in MHC-matched adult allogeneic bone marrow transplantation.
    Smyth LA; Herrmann RP; Christiansen FT; Hollingsworth PN; Townend DC; Edward E; Dawkins RL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1276-8. PubMed ID: 8442111
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic factors influence the development of acute graft-versus-host disease in adults undergoing allogeneic bone marrow transplantation.
    Smyth LA; Herrmann RP; Christiansen FT; Witt CS; Townend DC; Dawkins RL
    Transplant Proc; 1992 Oct; 24(5):2269. PubMed ID: 1413052
    [No Abstract]   [Full Text] [Related]  

  • 4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotyping analysis of HLA-class II and III genes in unrelated bone marrow transplantation among Japanese. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank.
    Mizuno S; Ohta H; Kamijima S; Kato Y; Maruya E; Saji H; Kamiya T; Kodera Y; Morishima Y
    Transplant Proc; 1995 Feb; 27(1):1383-4. PubMed ID: 7878921
    [No Abstract]   [Full Text] [Related]  

  • 9. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
    Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
    Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histocompatibility and bone marrow transplantation (BMT).
    Richter KV
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):445-50. PubMed ID: 2480287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
    van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
    Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTL clones isolated from an HLA-Cw-mismatched bone marrow transplant recipient with acute graft-versus-host disease.
    Sugimoto K; Murata M; Terakura S; Naoe T
    J Immunol; 2009 Nov; 183(9):5991-8. PubMed ID: 19812210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No influence of chromosome Y haplogroup variation in acute graft-versus-host disease in sardinia.
    Orofino MG; Contu D; Argiolu F; Sanna MA; Gaziev J; La Nasa G; Vacca A; Cao A; Cucca F
    Transplantation; 2006 Dec; 82(11):1529-32. PubMed ID: 17164727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation.
    MacMillan ML; Radloff GA; Kiffmeyer WR; DeFor TE; Weisdorf DJ; Davies SM
    Transplantation; 2003 Dec; 76(12):1758-62. PubMed ID: 14688528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of polymorphic adhesion molecules in the development of graft-versus-leukemia effect after HLA-matched allogeneic stem cell transplantation].
    Shiobara S; Sato H; Furukawa T; Tsukada J; Yasue S; Takeda H; Togawa A; Taira M; Sakai Y; Aizawa Y; Nakao S
    Rinsho Ketsueki; 2004 Jul; 45(7):518-23. PubMed ID: 15359910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell immunity and graft-versus-host disease (GVHD).
    Ichiki Y; Bowlus CL; Shimoda S; Ishibashi H; Vierling JM; Gershwin ME
    Autoimmun Rev; 2006 Jan; 5(1):1-9. PubMed ID: 16338205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of donor and recipient gender disparities on fatal graft-vs.-host disease in a mouse model for major histocompatibility complex-matched unrelated-donor bone marrow transplantation.
    OKunewick JP; Kociban DL; Machen LL; Buffo MJ
    Exp Hematol; 1993 Nov; 21(12):1570-6. PubMed ID: 8405238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.